Adial Pharmaceuticals
ADIL • NASDAQ
Adial Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Cary John Claiborne, with a market cap of $2.2M.
Market Cap$2.2M
Employees7.0
CEOCary John Claiborne
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 14, 2026 · in a monthQ1 2026
Financials
Adial Pharmaceuticals FAQ
Common questions about Adial Pharmaceuticals
Adial Pharmaceuticals is scheduled to report earnings for Q1 2026 on May 14, 2026.
Adial Pharmaceuticals has approximately 7 employees.